Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation. 1995

J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

The inhibition of low density lipoprotein (LDL) oxidation has been postulated as one mechanism by which antioxidants may prevent the development of atherosclerosis. Available data on the ability of beta-carotene to inhibit LDL oxidation are conflicting. We examined the role of in vivo and in vitro supplementation with beta-carotene on metal ion-dependent (cupric ions, Cu2+) and metal ion-independent (2,2'-azobis[2-amidinopropane]dihydrochloride, AAPH) oxidation of LDL as measured by the formation of conjugated dienes (absorbance at 234 nm). Sixteen subjects were supplemented with 50-100 mg of beta-carotene on alternate days for 3 weeks following a week-long loading dose of 100 mg/day. Plasma beta-carotene levels rose 5.5-fold, while LDL beta-carotene levels rose 8.5-fold. Oxidation of LDL by Cu2+ or AAPH was not significantly delayed after in vivo supplementation with beta-carotene compared with baseline. For AAPH, the lag phase (in minutes) was 75 +/- 8 at baseline and 83 +/- 14 after supplementation (P = 0.07). For Cu2+, the lag phase was 172 +/- 41 at baseline and decreased to 130 +/- 24 after supplementation (P < 0.01). Similarly, no protective effect against Cu(2+)-induced oxidation was observed when beta-carotene was added to LDL in vitro. Supplementation of plasma with beta-carotene in vitro prior to LDL isolation also did not enhance LDL's resistance to Cu(2+)- or AAPH-induced oxidation, despite a 5-fold increase in LDL beta-carotene levels over vehicle control.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002338 Carotenoids The general name for a group of fat-soluble pigments found in green, yellow, and leafy vegetables, and yellow fruits. They are aliphatic hydrocarbons containing 4 terpene subunits. Carotenes,Carotenoid,Tetraterpene Derivatives,Tetraterpenes,Carotene,Derivatives, Tetraterpene
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D019207 beta Carotene A carotenoid that is a precursor of VITAMIN A. Beta carotene is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC). Betacarotene,BellaCarotin,Carotaben,Max-Caro,Provatene,Solatene,Vetoron,beta-Carotene,Carotene, beta,Max Caro,MaxCaro

Related Publications

J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
May 1999, Free radical biology & medicine,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
December 1993, Circulation,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
May 1992, Arteriosclerosis and thrombosis : a journal of vascular biology,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
June 1997, Indian journal of biochemistry & biophysics,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
October 1995, Scandinavian journal of clinical and laboratory investigation,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
June 1998, Molecular and cellular biochemistry,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
March 1999, British journal of clinical pharmacology,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
June 1996, Israel journal of medical sciences,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
February 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
J M Gaziano, and A Hatta, and M Flynn, and E J Johnson, and N I Krinsky, and P M Ridker, and C H Hennekens, and B Frei
December 2000, Free radical biology & medicine,
Copied contents to your clipboard!